Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may help women with low sexual desire after surgical menopause.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Medical care for transgender youth should be individualized and supportive.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

The treatment successfully lowered testosterone levels and reduced symptoms.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone increases hair growth and acne in transgender men.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Hormone therapy might help improve women's appearance as they age.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

New treatments for male hypogonadism are effective and should be personalized.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.